IV Year Pharm. D
Sub Code: 4.5 BIOPHARMACEUTICS AND PHARMACOKINETICS [THEORY]
After a successful completion of the course the students will be able to
| Course outcome number | Course Outcomes | Cognitive level |
|---|---|---|
| CO1 | Remembering: Recall and describe the processes of drug absorption, distribution, and elimination. This involves remembering key details and steps involved in these pharmacokinetic processes. | C1 |
| CO2 | Understanding: Explain the processes of drug absorption, distribution, and elimination. This involves grasping the underlying principles and concepts that govern these processes. | C2 |
| CO3 | Applying: Calculate various pharmacokinetic parameters from plasma and urinary excretion data by applying a one-compartment model. This involves using knowledge and mathematical skills to apply a specific pharmacokinetic model to real-world data. | C3 |
| CO4 | Analyzing: Determine various pharmacokinetic parameters from either plasma concentration or urinary excretion data for a drug by applying a multi-compartment model. This requires breaking down complex data and applying mathematical and analytical skills to derive pharmacokinetic parameters in a more complex setting. | C4 |
| CO5 | Evaluating: Use plasma drug concentration-time data to calculate the pharmacokinetic parameters of a drug product by nonlinear pharmacokinetics. This level involves critical assessment and decision-making based on complex pharmacokinetic data, particularly when nonlinear processes are involved. | C5 |
| CO6 | Creating: Design bioavailability and bioequivalence studies of drugs or dosage forms. This involves synthesizing information and creating study protocols that adhere to regulatory standards and scientific principles, considering factors such as study design, data analysis, and interpretation. | C6 |
Remembering (C1), Understanding (C2), Applying (C3), Analyzing (C4), Evaluating (C5) and Creating (C6)
IV Year Pharm. D
Sub Code: 4.5 BIOPHARMACEUTICS AND PHARMACOKINETICS (Practical)
After a successful completion of the course the students will be able to
| Course outcome number | Course Outcomes | Psychomotor level |
|---|---|---|
| CO1 | Remembering: Recall the methods used to determine the dissolution characteristics and compare different marketed products of slightly soluble drugs. This involves remembering specific techniques and approaches used in dissolution studies. | P1 |
| CO2 | Understanding: Explain the principles behind protein binding studies for highly protein-bound and poorly protein-bound drugs. Understand the concept of plasma-protein binding and its relevance in pharmacokinetics. | P2 |
| CO3 | Applying: Apply the methods and techniques for conducting plasma-protein binding studies on the same drug (highly and poorly protein-bound) at different concentrations while maintaining a constant time point. This involves hands-on application of experimental procedures. | P3 |
| CO4 | Analyzing: Analyze the results of bioavailability studies conducted on animal or human models. This includes data interpretation, statistical analysis, and drawing conclusions based on the study outcomes. | P4 |
| CO5 | Evaluating: Evaluate the significance of different pharmacokinetic parameters calculated from plasma and urinary excretion data. Determine how these parameters relate to drug behavior and its effects in the body. Assess the impact of variations in these parameters on drug therapy. | P5 |
| CO6 | Creating: Design and plan bioavailability studies for commonly used drugs in animal or human models. This involves creating study protocols, selecting appropriate analytical methods, and defining the parameters to be measured in order to assess drug bioavailability. | P6 |
